Difference of Platelet Count in Patients with Tuberculosis Before and After 1 Month of Treatment with Anti Tuberculosis Drug
DOI:
https://doi.org/10.31983/jlm.v7i1.12798Keywords:
Platelet Count, Hematology, Treatment, TuberculosisAbstract
Tuberculosis (TB) is still one of the infectious diseases with the highest mortality rate in the world. WHO stated that Indonesia is the third country in the world with the most TB cases. Semarang is the third province in Indonesia with the highest TB cases. Although the mortality rate is high, in reality TB can be treated and prevented. Anti-TB drugs as TB treatment agents can cause side effects, one of which is a decrease in the number of platelets. The purpose of this study was to determine the difference in the number of platelets in TB patients before starting treatment and after one month of treatment with Anti-TB drugs. The study population was new tuberculosis patients. The study sample was taken according to the established criteria and obtained as many as 24 people, who were examined twice, namely before treatment and after 1 month of treatment. The results of this study stated that the average number of platelets before starting TB treatment was 340.875 cells/μL and after one month of treatment with Anti-TB drugs was 281.958 cells/μL. The Wilcoxon test showed a P value = 0.009. There was a significant difference in the number of platelets before starting TB treatment and after one month of treatment with Anti-TB drugs. TB treatment can affect blood conditions, including platelets. Thus, patients and their families are expected to better  understand the importance of carrying out routine checks and not stopping treatment without medical consultation.
References
Abulfathi, A. A., Decloedt, E. H., Svensson, E. M., Diacon, A. H., Donald, P., & Reuter, H. (2019). Clinical Pharmacokinetics and Pharmacodynamics of Rifampicin in Human Tuberculosis. Clinical Pharmacokinetics, 58(9), 1103–1129. https://doi.org/10.1007/s40262-019-00764-2
Anggreani, N., Wulan, I., Sudarsono, Analisawati, Tantri, Wardani, K., Pratiwi, D., Rahaju, & Minto. (2023). Pengaruh Pemberian Obat Anti Tuberkulosis (OAT) Terhadap Jumlah Trombosit pada Pasien TB Paru di BKPM Purwokerto. Jurnal Surya Medika, 9(3), 92–100. https://doi.org/10.33084/jsm.v9i3.6473
Dinas Kesehatan Kota Semarang. (2022). Dasbord Kesehatan Dinkes Kota Semarang 2022.pdf. Dinas Kesehatan. http://119.2.50.170:9095/dashboardNew/
Dotulong. (2015). Hubungan faktor risiko umur, jenis kelamin, dan kepadatan hunian dengan kejadin TB paru di desa wori. Jurnal Kedokteran Tropik, 1(3), 1–10. https://ejournal.unsrat.ac.id/v2/index.php/JKKT/article/view/7773
Durachim, A., & Astuti, D. (2018). Bahan Ajar Hemostasis. In Kementerian Kesehatan Republik Indonesia (Vol. 1, Issue 1, pp. 1–237). https://medlab.id/download-ebook-hemostasis/
Isbaniah, F., Burhan, E., Sinaga, B. Y., Behtri, D., Yanifitri, Handayani, D., Harsini, Agustin, H., Artika, I. N., Aphridasari, J., Rohani Lasmaria, R., Soedarsono, Sugiri, & R., Y. J. (2021). Tuberkulosis Pedoman Diagnosis dan Penatalaksanaan di Indonesia. In Perhimpunan Dokter Paru Indonesia (Revisi 2, Vol. 001, Issue 2014). Perhimpunan Dokter Paru Indonesia. https://klikpdpi.com/bukupdpi/wp-content/uploads/2022/08/BUKU-GUIDELINE-TB-2021.pdf
Kalma, K., Rafika, R., & Bahctiar, A. R. (2019). Platelet and Hemoglobin Concentration in Tuberculosis Patients With Anti-Tuberculosis Medication. Jurnal Media Analis Kesehatan, 10(2), 143. https://doi.org/10.32382/mak.v10i2.1302
Karwiti, W., Sri Lestari, W., Rezekiyah, S., & Kesehatan Jambi, P. (2021). Perbedaan Profil Hematologi Pada Penderita Tuberkulosis Paru Yang Menjalani Pengobatan. Jambura Journal of Health Science and Research, 3(1), 126–132. https://doi.org/https://doi.org/10.35971/jjhsr.v3i1.8350
Kementerian Kesehatan RI. (2020). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Tuberkulosis. In Dirjen Pencegahan Pengendalian Penyakit (2020th ed., Vol. 11, Issue 1). Kemenkes RI.
Kementerian Kesehatan RI. (2022). Rokok & TBC. https://p2ptm.kemkes.go.id/kegiatan-p2ptm/dki-jakarta/rokok-tbc-pengendalian-konsumsi-rokok-adalah-salah-satu-strategi-eliminasi-tuberkulosis
Kirwan, D. E., Chong, D. L. W., & Friedland, J. S. (2021). Platelet Activation and the Immune Response to Tuberculosis. Frontiers in Immunology, 12(May), 1–11. https://doi.org/10.3389/fimmu.2021.631696
Koumpis, E., Papathanasiou, K., Papakonstantinou, I., Tassi, I., Serpanou, A., Kapsali, E., & Hatzimichael, E. (2021). Rifampicin-Induced Thrombocytopenia: A Case Report and Short Review of the Literature. European Medical Journal, April. https://doi.org/10.33590/emj/20-00193
Maharani, E. A., & Noviar, G. (2018). Bahan Ajar TLM Imunohematologi Dan Bank Darah. In Kemenkes RI (2018th ed., Vol. 11, Issue 1). Kemenkes RI. https://drive.google.com/file/d/1e1BHtyEoZDPhmIGbuYDFsCFlZW--2vtH/view
Mandal, S. K., & Chavan. (2016). Hematological Profile in Patients Suffering From Tuberculosis and Treatment Response. Journal Of Medical Science And Clinical Research, 04(October), 13189–13192. https://www.jmscr.igmpublication.org/home/index.php/archive/91-volume-4-issue-10-oct-2016/1186-hematological-profile-in-patients-suffering-from-tuberculosis-and-treatment-response
Nafsi, A. Y., & Rahayu, S. R. (2020). Analisis Spasial Tuberkulosis Paru Ditinjau dari Faktor Demografi dan Tingkat Kesejahteraan Keluarga di Wilayah Pesisir. Jurnal Penelitian Dan Pengembangan Kesehatan Masyarakat Indonesia, 1(1), 72–82. https://doi.org/10.15294/jppkmi.v1i1.41419
Pradipta, I. S., Idrus, L. R., Probandari, A., Lestari, B. W., Diantini, A., Alffenaar, J. W. C., & Hak, E. (2021). Barriers and strategies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient’s perspective. BMC Public Health, 21(1), 1–12. https://doi.org/10.1186/s12889-021-12005-y
Ranucci, M., Aloisio, T., Dedda, U. Di, Menicanti, L., de Vincentiis, C., & Baryshnikova, E. (2019). Gender-based differences in platelet function and platelet reactivity to P2Y12 inhibitors. PLoS ONE, 14(11), 1–11. https://doi.org/10.1371/journal.pone.0225771
Rosaline, M. D., & Herlina, S. (2021). Kami-Pmo Tb (Edukasi Dan Pendampingan Pengawas Menelan Obat Tb) Dalam Pengendalian Mdr Tb. Jurnal Bakti Masyarakat Indonesia, 3(2), 398–407. https://doi.org/10.24912/jbmi.v3i2.9475
Wikandari, R. J., Surati, Nuryani, S., & Sistiyono. (2024). Hematological Profile of Pulmonary Tuberculosis Patients Before and After 1 Month of Taking Anti-TB Drugs. Jurnal Teknologi Laboratorium, 3(2), 135–144. https://doi.org/10.29238/teknolabjournal.v13i2.486
World Health Organization, (WHO). (2021). Global Tuberculosis Report 2021. In (WHO) World Health Organization (Ed.), World Health Organization. World Health Organization. https://www.who.int/publications/i/item/9789240037021
World Health Organization, (WHO). (2023). Global Tuberculosis Report 2023. In (WHO) World Health Organization (Ed.), January. https://iris.who.int/
Downloads
Additional Files
Published
Issue
Section
License
This journal provides direct open access to content on the principle that conducting research is freely available to the public supporting a greater global exchange of knowledge.
This journal provides open access to content in essence which can be used for globalization.
